MedTrace Logo

Brain Effects of Opiate Agonist and Antagonist

NCT04342130 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2021-05-07

Study results available
· View outcomes & findings →

Summary

This study will look at the short-term effect of morphine on brain response to food.

Conditions

  • Chronic Low-back Pain

Interventions

DRUG

Morphine

30 mg oral tablet

Sponsors & Collaborators

  • University of Rochester

    lead OTHER

Principal Investigators

  • Paul Geha, MD · Department of Psychiatry in University of Rochester

Study Design

Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-04-27
Primary Completion
2019-04-16
Completion
2019-04-16
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04342130 on ClinicalTrials.gov